AWARD
A -- Nociceptin Receptor (NOP) Agonists for Alcohol Use Disorders
- Notice Date
- 2/20/2013
- Notice Type
- Award Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, R&D Contracts Management Branch, 5635 Fishers Lane, Room 3016, MSC 9304, Bethesda, Maryland, 20892-9304
- ZIP Code
- 20892-9304
- Solicitation Number
- PHS2012-1
- Point of Contact
- Patricia N. Hanacek, Phone: 301-594-6226, Paul McFarlane, Phone: 301-443-1191
- E-Mail Address
-
hanacekp@mail.nih.gov, pmcfarlane@mail.nih.gov
(hanacekp@mail.nih.gov, pmcfarlane@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Award Number
- HHSN275201300005C
- Award Date
- 2/15/2013
- Awardee
- Astraea Therapeutics, LLC, 320 Logue Avenue, Suite 142<br />, Mountain View, California 94043, United States
- Award Amount
- $297,170
- Line Number
- 1
- Description
- SBIR Phase I: 'Nociceptin Receptor (NOP) Agonists for Alcohol Use Disorders' The Goal of this contract is to develop potent and selective NOP agonists, specifically optimized for their drug-like suitability, and to assess the effect of a selected optimized NOP agonist on ethanol-induced conditioned place preference. The outcome of this project will be the identification of efficacious NOP agonist drug candidates, suitable for further development as potential pharmacotherapy for alcohol and relapse prevention.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAAA/Awards/HHSN275201300005C.html)
- Record
- SN02991928-W 20130222/130220235018-0f86d123d2b8f3fdb8eb1bf7573b4c78 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |